LABVANTAGE Signs Global Contract with Prominent Diagnostic Organization

Somerset, NJ. March 14, 2012 

LABVANTAGE announced today that its laboratory information management system (LIMS) and electronic laboratory notebook (ELN) were selected by a world-class provider that specializes in in vitro infectious disease diagnostics, including designing, developing, manufacturing and marketing reagents and automated instruments for medical analyses and cosmetics, and product quality control in the agro-food and pharmaceutical industries. The initial contract in excess of $3M will span global operations with numerous subsidiaries to harmonize processes and leverage the benefits of deploying a single, global LIMS across all laboratory sites. The harmonized configuration, testing, and compliance protocols to all sites worldwide will enable better decision-making and conformance while minimizing the impact to individual sites’ maintenance and support.

 

“We are very pleased that this prominent advocate for improving public health has chosen LABVANTAGE after its thorough global due diligence effort,” states Jeff Ferguson, LABVANTAGE Chief Executive Officer. “This significant commitment serves to further validate our strategy of increased investment in products and people that enable our customers to increase the pace of product development while decreasing their total cost of laboratory operations across all departments and locations.”

With over 6,000 employees worldwide and revenue in the billions, the organization will implement LABVANTAGE initially in its quality management laboratories and expand
to include worldwide R&D sites in future phases. The LABVANTAGE system will initially interface with other applications, such as SAP, OpenText Corporations’s LiveLink ECM, Cognos BI, Sparta System’s Trackwise for training and quality management, and numerous laboratory instruments using the LABVANTAGE Connect instrument integration software.